ALNY vs GSIT · P/E 76, rev $1.29B vs rev $25.1M
Alnylam Pharmaceuticals Inc (ALNY) versus GSI Technology Inc (GSIT) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
GSI Technology Inc (GSIT) is a semiconductors company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported GSIT revenue for 2026-03-31 was $25.1M. Net income was -$13.2M. GSIT currently screens at market cap $126.5M.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. GSIT currently screens at market cap $126.5M.
Not investment advice. Open the ALNY and GSIT stock pages for the full models.
Not investment advice.